RNA干扰效应器选择性地沉默致病变体GNAO1c.607 G > A In Vitro选择性地沉默致病变体
Natalia V Klementieva1,2, Evgenii A Lunev1,2,3, Anna A Shmidt1,2,3
1Laboratory of Modeling and Gene Therapy of Hereditary Diseases, Institute of Gene Biology Russian Academy of Sciences, Moscow, Russia.
Nucleic acid therapeutics
|January 12, 2024
概括
RNA干扰 (RNAi) 疗法可以针对主要的遗传疾病. 这项研究开发了RNAi工具来抑制导致GNAO1脑病变的GNAO1变体,显示出成功的等位基因歧视和突变蛋白减少.
科学领域:
- 遗传学 遗传学是一种遗传学.
- 分子生物学分子生物学
- 神经科学是一个神经科学.
背景情况:
- 主导性遗传性疾病可以通过向特定基因产物使用RNA干扰 (RNAi) 来治疗.
- GNAO1脑病变是由异合的GNAO1 c.607 G>A变体引起的,具有特定序列抑制的目标.
研究的目的:
- 开发用于选择性抑制致病性GNAO1 c.607G>A变体的RNAi疗法.
- 为了评估短干扰RNA (siRNA) 和基于腺相关病毒 (AAV) 的短毛RNA (shRNA) 对于GNAO1变体沉默的有效性和选择性.
主要方法:
- 对siRNA候选者的查,以确定有效的GNAO1变异向.
- 工程 AAV-交付的shRNA构造与修改的干循环结构改进的RNAi.
- 评估基因歧视和突变蛋白向下调节对RNAi作用因子的反应.
主要成果:
- si1488 siRNA候选人至少表现出双重的等位基区分,并将突变GNAO1蛋白减少了35%.
- 通过AAV载体传递的所有测试的shRNA结构都对突变GNAO1等位基因具有选择性,发针结构修改的影响很小.
- 在AAV载体转导的背景下,shRNA介导的沉默选择性得到证实.
结论:
- 包括siRNA和AAV-RNAi在内的RNAi作用因子可以有效地抑制致病性GNAO1 c.607G>A变体,并根据单个核酸替代区分基因.
- 对患者特异性神经元和动物模型的进一步研究对于推进这些RNAi效应器对于GNAO1脑病变基因疗法开发至关重要.
相关概念视频
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K
Nonsense-mediated mRNA Decay
10.6K
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
10.6K
In-vitro Mutagenesis
13.9K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
13.9K
siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
Leaky Scanning
5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K


